344 related articles for article (PubMed ID: 15655551)
1. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects.
Taylor DD; Gerçel-Taylor C
Br J Cancer; 2005 Jan; 92(2):305-11. PubMed ID: 15655551
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated exosomes and their modulation of T cell signaling.
Taylor DD; Akyol S; Gercel-Taylor C
J Immunol; 2006 Feb; 176(3):1534-42. PubMed ID: 16424182
[TBL] [Abstract][Full Text] [Related]
3. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
Taylor DD; Gerçel-Taylor C; Lyons KS; Stanson J; Whiteside TL
Clin Cancer Res; 2003 Nov; 9(14):5113-9. PubMed ID: 14613988
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomes.
Zhang Y; Wu XH; Luo CL; Zhang JM; He BC; Chen G
Int J Mol Med; 2010 May; 25(5):695-700. PubMed ID: 20372811
[TBL] [Abstract][Full Text] [Related]
5. The potential of exosomes in immunotherapy.
Chaput N; Taïeb J; André F; Zitvogel L
Expert Opin Biol Ther; 2005 Jun; 5(6):737-47. PubMed ID: 15952905
[TBL] [Abstract][Full Text] [Related]
6. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences.
Sabapatha A; Gercel-Taylor C; Taylor DD
Am J Reprod Immunol; 2006; 56(5-6):345-55. PubMed ID: 17076679
[TBL] [Abstract][Full Text] [Related]
7. Malignant effusions and immunogenic tumour-derived exosomes.
Andre F; Schartz NE; Movassagh M; Flament C; Pautier P; Morice P; Pomel C; Lhomme C; Escudier B; Le Chevalier T; Tursz T; Amigorena S; Raposo G; Angevin E; Zitvogel L
Lancet; 2002 Jul; 360(9329):295-305. PubMed ID: 12147373
[TBL] [Abstract][Full Text] [Related]
8. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides.
Hsu DH; Paz P; Villaflor G; Rivas A; Mehta-Damani A; Angevin E; Zitvogel L; Le Pecq JB
J Immunother; 2003; 26(5):440-50. PubMed ID: 12973033
[TBL] [Abstract][Full Text] [Related]
9. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex.
Blanchard N; Lankar D; Faure F; Regnault A; Dumont C; Raposo G; Hivroz C
J Immunol; 2002 Apr; 168(7):3235-41. PubMed ID: 11907077
[TBL] [Abstract][Full Text] [Related]
10. HSP-10 in ovarian cancer: expression and suppression of T-cell signaling.
Akyol S; Gercel-Taylor C; Reynolds LC; Taylor DD
Gynecol Oncol; 2006 Jun; 101(3):481-6. PubMed ID: 16386781
[TBL] [Abstract][Full Text] [Related]
11. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.
Peng P; Yan Y; Keng S
Oncol Rep; 2011 Mar; 25(3):749-62. PubMed ID: 21181093
[TBL] [Abstract][Full Text] [Related]
12. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes.
Skokos D; Le Panse S; Villa I; Rousselle JC; Peronet R; David B; Namane A; Mécheri S
J Immunol; 2001 Jan; 166(2):868-76. PubMed ID: 11145662
[TBL] [Abstract][Full Text] [Related]
13. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
Skov S; Bregenholt S; Claesson MH
J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
[TBL] [Abstract][Full Text] [Related]
14. Tumour-released exosomes and their implications in cancer immunity.
Iero M; Valenti R; Huber V; Filipazzi P; Parmiani G; Fais S; Rivoltini L
Cell Death Differ; 2008 Jan; 15(1):80-8. PubMed ID: 17932500
[TBL] [Abstract][Full Text] [Related]
15. Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling.
Wahlgren J; Karlson Tde L; Glader P; Telemo E; Valadi H
PLoS One; 2012; 7(11):e49723. PubMed ID: 23166755
[TBL] [Abstract][Full Text] [Related]
16. [Tumour-derived exosomes and their roles in cancer].
Wang K; Tang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1288-92. PubMed ID: 21200099
[TBL] [Abstract][Full Text] [Related]
17. Direct exosome stimulation of peripheral human T cells detected by ELISPOT.
Admyre C; Johansson SM; Paulie S; Gabrielsson S
Eur J Immunol; 2006 Jul; 36(7):1772-81. PubMed ID: 16761310
[TBL] [Abstract][Full Text] [Related]
18. Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis.
Gercel-Taylor C; O'Connor SM; Lam GK; Taylor DD
J Reprod Immunol; 2002; 56(1-2):29-44. PubMed ID: 12106882
[TBL] [Abstract][Full Text] [Related]
19. MHC class I antigens regulate CD3-induced tyrosine phosphorylation of proteins in T cells.
Dasgupta JD; Granja CB; Yunis EJ; Relias V
Int Immunol; 1994 Mar; 6(3):481-9. PubMed ID: 8186200
[TBL] [Abstract][Full Text] [Related]
20. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
